Table 3

Examples of clinical indicators from CareTrack Australia 1 that were written in plain English, one concept at a time using a structured and standardised format

Condition	Original recommendation (source)	Level of evidence	Indicator
Asthma	Treatment with a preventer medication is recommended for patients who have asthma symptoms more than three times per week or use a SABA more than three times per week50	I	Patients who reported asthma symptoms more than three times per week were prescribed preventer medication (Seretide, Symbicort, Flixotide)
Asthma		I	Patients with asthma who report using SABA more than three times per week were prescribed preventer medication
Hypertension	Initiate antihypertensive drug treatment immediately in patients with hypertension with any of the following: grade 3 hypertension or isolated systolic hypertension with widened pulse pressure (SBP ≥160 mm Hg and DBP ≤70 mm Hg) associated conditions or evidence of end-organ damage (regardless of BP) high absolute risk of cardiovascular disease, based on the presence of markers of high risk or as estimated using a risk calculator51	Consensus-based recommendation	Patients with hypertension and isolated SBP ≥160 and DBP <70 or with widening pulse pressure are prescribed antihypertensive therapy
			Patients with hypertension and end-organ failure are prescribed antihypertensive therapy
			Patients with hypertension and at high risk (diabetes, previous stroke/CVA or chronic kidney disease) of developing coronary heart disease are prescribed antihypertensive therapy

BP, blood pressure; CPG, clinical practice guideline; CVA, cerebrovascular accident; DBP, diastolic blood pressure; SABA, short-acting beta2-agonist; SBP, systolic blood pressure.